Add BrightSurf on Google Email

Search results for “Oncology”

1,000+ results for "Oncology"

APSHO and Hope Foundation launch educational courses for advanced practitioners in oncology care

The Advanced Practitioner Society of Hematology and Oncology (APSHO) has launched two new educational courses for advanced practitioners in oncology care, developed in collaboration with The Hope Foundation for Cancer Research. The self-paced online courses provide practical, evidence-informed education focused on real-world clinical p...

Wash U Medicine Cancer study professional recognized with Clinical Research Integrity Award by Alliance for Clinical Trials in Oncology

Jennifer Frederick, an oncology clinical trial organizer at Wash U Medicine, received the 2026 Alliance Clinical Research Professionals Research Integrity Service Award for her dedication to helping cancer patients access clinical trials. Her work ensures that trials run smoothly and safely, with a focus on patient advocacy and compass...

Three-week radiation course a safe option for breast cancer patients undergoing reconstruction, Alliance trial shows

A new trial shows that a shorter three-week radiation course is as safe and effective as the standard five-week treatment for women undergoing breast reconstruction. The RT CHARM trial found no increase in complications or effects on reconstruction efforts.

SourceAlliance for Clinical Trials in Oncology·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateOct 21, 2026

UT MD Anderson names 2026 winners of The Brown Foundation Award for Excellence in Oncology Nursing

The University of Texas MD Anderson Cancer Center has awarded Lakeisha Keller-Davis, RN, MSN, CMSRN, and Ellen C. Mullen, Ph.D., APRN-BC, with the 2026 Brown Foundation Award for Excellence in Oncology Nursing. The awards recognize exceptional patient care, clinical practice, leadership, and commitment to improving patient outcomes.

JACR study explores discrepancies among paid family and medical leave policies across U.S. academic and radiation oncology departments

A recent study found that paid family and medical leave policies are widely available but inconsistently implemented across US academic radiology and radiation oncology departments. Most programs require faculty to use vacation or sick time with variable allowance, and few employees utilized leave in the previous year.

SourceAmerican College of Radiology·JournalJournal of the American College of Radiology·TypeSurvey·DateOct 15, 2026

NCCN highlights collaborations to improve global cancer outcomes during meetings in North America and Asia

NCCN has published regional cancer treatment guidelines for the Philippines, tailored to the local setting and regulatory environment. The guidelines reflect collaborations with global organizations, including the International Gynecologic Cancer Society and the Philippine Society of Medical Oncology, to improve access to high-quality ...

Model traces C. diff spread in hospital oncology units

A new study models C. diff transmission in oncology units, revealing that asymptomatic colonized patients are the primary source of new infections. The model provides a clearer picture of C. diff transmission events and could help inform protocols to prevent future disease transmission.

SourceNorth Carolina State University·JournalInfection Control and Hospital Epidemiology·TypeComputational simulation/modeling·DateOct 5, 2026

NRG Oncology Trial Finds No Difference in NeurocoNRG Oncology trial finds no difference in neurocognitive outcomes, but improved overall survival with stereotactic radiosurgery for SCLC brain metastases

A Phase III trial found stereotactic radiosurgery (SRS) improved overall survival in patients with small cell lung cancer (SCLC) brain metastases without significant difference in neurocognitive outcomes compared to hippocampal-avoidant whole brain radiotherapy (HA-WBRT).

Alliance trial finds fractionated radiosurgery reduces cancer recurrence after surgery for large brain metastases

A Phase III trial found that delivering focused radiation therapy over three to five sessions after surgery for a large brain metastasis reduced cancer recurrence at the surgical site. Fractionated stereotactic radiosurgery also showed a trend in controlling brain metastases that had not been removed surgically. Median overall survival...

SourceAlliance for Clinical Trials in Oncology·TypeRandomized controlled/clinical trial·DateSep 28, 2026

Penn Medicine and IBA launch joint venture to advance proton therapy and radiation oncology program development worldwide

The new company will provide integrated advisory and lifecycle support services to help healthcare organizations develop and sustain successful proton therapy programs. Penn Medicine and IBA will combine their expertise to create a unique platform for delivering exceptional care to patients and building sustainable oncology programs.

BMJH-SANKALP Center for Paediatric Haematology, Oncology and Bone Marrow Transplantation becomes India's first JACIE-certified center

The BMJH Sankalp Center for Paediatric Haematology Oncology has achieved JACIE certification, a landmark milestone for haematopoietic cell transplantation and cellular therapy in India. This certification ensures safe and effective care for children with life-threatening blood disorders.

Patient-reported outcome analysis of NRG Oncology trial in limited-stage small cell lung cancer suggests more favorable quality-of-life trajectory with twice-daily versus once-daily radiation - results published

The NRG-LU005 trial found that patients receiving twice-daily radiation experienced a more favorable quality-of-life trajectory than those receiving once-daily radiation. This association remained after adjusting for patient characteristics, although the radiation schedule was not randomized.

SourceNRG Oncology·JournalJournal of Thoracic Oncology·DateAug 25, 2026

NRG Oncology trial results show favorable bowel health related quality of life outcomes for localized immediate risk prostate cancer treated with stereotactic body radiation therapy – Results published

The NRG-GU005 trial shows that SBRT improves bowel health related quality of life in localized intermediate risk prostate cancer patients, with no significant impact on urinary HRQOL. SBRT is also associated with lower incontinence related quality of life and improved maintenance of erectile dysfunction compared to hypofractionated IMRT.

SourceNRG Oncology·JournalJournal of the American Medical Association·DateAug 25, 2026

NRG Oncology adds new leadership members to Clinical Research Associate and Mentorship Subcommittees, Translational Science Committee

NGR Oncology has appointed multiple new leadership members to various subcommittees, including Rebecca Arend as Gynecology Oncologist Vice Chair of the Translational Science Committee and Robin Lockhorst as Chair of the Pharmacy Subcommittee. David Miyamoto was also appointed Radiation Oncology Vice Chair of the Translational Science C...

Virtual, sustained smoking cessation program for cancer patients doubles quitting rate, clinical trial shows

A new study found that a virtual smoking cessation treatment program nearly doubled quit rates for cancer patients who currently smoke. The program, delivered at community oncology care settings, was both cost-effective and satisfying for patients. Participants who completed more sessions had a higher likelihood of quitting.

SourceMass General Brigham·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateJul 14, 2026

Loss of radiation therapy clinics could widen cancer care gaps across the united states

A nationwide analysis found that many radiation oncology clinics have closed, particularly in rural communities, reducing access to lifesaving cancer treatment. The study suggests that understanding which communities are most vulnerable can help policymakers develop strategies to preserve access.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalInternational Journal of Radiation Oncology*Biology*Physics·TypeData/statistical analysis·DateJul 10, 2026

50 million Americans live in counties without a radiation oncology clinic, study finds

A new study found that over 50 million Americans live in counties without a radiation oncology clinic, highlighting vulnerabilities in the nation's cancer care infrastructure. Radiation oncology practices have closed disproportionately in rural areas and freestanding settings, raising concerns about patients' access to cancer care.

SourceAmerican Society for Radiation Oncology·JournalInternational Journal of Radiation Oncology*Biology*Physics·DateJul 9, 2026

Terasaki Institute researchers and key pioneers publish comprehensive review on glioma organoid models, proposing new classification framework for brain cancer research

Terasaki Institute researchers and key pioneers publish comprehensive review on glioma organoid models, proposing a foundational classification framework to guide translational brain tumor research. The review provides an overview of human glioma organoid systems and aims to address methodological heterogeneity in the field.

SourceTerasaki Institute for Biomedical Innovation·JournalNeuro-Oncology·TypeLiterature review·DateJun 15, 2026

Elsa Anagnostou, Jordan Berlin, and Olisaemeka Ogbue receive ECOG-ACRIN 2026 scientific leadership and mentorship awards

Valsamo Anagnostou, Jordan Berlin, and Olisaemeka Ogbue receive ECOG-ACRIN's Young Investigator Award, Remarkable Mentor in Oncology Award, and Paul Carbone, MD Fellowship Award for outstanding contributions to translational research, mentorship, and improving cancer care. The awards are funded by the ECOG Research & Education Foundation.

Internationally recognized oncology drug development leader and melanoma expert joins HonorHealth Research Institute

Dr. Nageatte Ibrahim brings her expertise in immunotherapy and cancer drug development to HonorHealth Research Institute, focusing on advancing novel treatments and improving patient outcomes. The institute aims to develop collaborations with leading research centers worldwide to bring cutting-edge therapies to patients in need.

SourceHonorHealth Research Institute·TypeRandomized controlled/clinical trial·DateJun 4, 2026

ASCO: Targeted therapy combo nearly doubles time without disease progression for patients with advanced colorectal cancer

A Phase 3 trial showed a 56% reduction in the risk of disease progression or death for patients with BRAF V600E mutant metastatic colorectal cancer treated with a targeted therapy combination. The treatment improved median progression-free survival and overall survival, with nearly 75% of patients alive at 18 months.

JMIR Publications showcases precision oncology success: individualized multi-drug therapy outperforms standard care

A new article in JMIR Publications showcases precision oncology's success, where individualized multi-drug regimens improve treatment responses and survival rates for patients with advanced cancers. The study found that closely matching drug therapies to tumor mutations leads to better outcomes, while also offering a safer profile.

SourceJMIR Publications·JournalJournal of Medical Internet Research·TypeCommentary/editorial·DateApr 6, 2026

NRG Oncology adds new leadership members to ancillary projects, investigator & career development, medical oncology, patient-centered outcomes research, and surgical oncology committees & sarcoma subcommittee

NRG Oncology has appointed Dr. John Nakayama as Vice Chair of the NRG Ancillary Projects Committee, Dr. Ibrahim Nassour as Vice Chair of the Surgical Oncology Committee, and Dr. Scott Okuno as Vice Chair of the Sarcoma Subcommittee. Dr. Angeles Alvarez Secord was also appointed Chair of the Investigator & Career Development Committee.